摘要
目的探讨甲磺司特颗粒治疗儿童支气管哮喘的临床疗效。方法选取我院2014年10月~2016年1月收治的92例支气管哮喘患儿,按照随机数字表法分为研究组和对照组每组各46例,研究组采用甲磺司特治疗,对照组采用常规方法治疗,比较两组临床疗效、临床症状改善时间、肺功能改善情况。结果与对照组比较,研究组的治疗总有效率更高,喘息、呼吸困难、肺部哮鸣音消失时间更短,差异有统计学意义（P〈0.05）。治疗后两组FEV1、PEF均较治疗前有明显改善,差异有统计学意义（P〈0.05）;治疗后,研究组FEV1、PEF高于对照组,差异有统计学意义（P〈0.05）。结论儿童支气管哮喘采用甲磺司特治疗疗效确切,可有改善患儿的肺功能,有效缓解临床症状,可作为一种安全有效的治疗儿童支气管哮喘的药物。
Objective To investigate the clinical efficacy of suplatast tosilate particles in the treatment of children with bronchial asthma.Methods 92 cases of bronchial asthmatic children in our hospital for treatment were selected from October 2014 to January 2016,all the patients were divided into study group and control group according to the random number table,there were 46 cases in the study group and the control group,the patients in the study group were treated with methane sulfonamide Sterling,the patients in the control group were treated with conventional therapy,the clinical efficacy,clinical improvement time,lung function improvement of two groups were compared.Results The total effective rate of the study group was significant higher than the control group,the wheezing,difficulty breathing,wheezing lungs disappeared time was significant shorter than the control group,there were significant difference between two groups（P〈0.05）. After treatment,FEV1,PEF of two groups was significant higher than before treatment,there were significant difference between after treatment and before treatment（P〈0.05）; FEV1,PEF of the study group after treatment was higher than the control group,there was significant difference between two groups（P〈0.05）. Conclusion Clinical effect of bronchial asthma in children treated with suplatast special is better,it can improve the lung function of children,and can relieve the symptoms,it can be used as a safe and effective treatment of children with bronchial asthma drugs and can be clinical application.
出处
《中国继续医学教育》
2016年第17期179-181,共3页
China Continuing Medical Education
